The in vitro pharmacology of the peripherally restricted opioid receptor antagonists, alvimopan, ADL 08-0011 and methylnaltrexone

Author： Beattie D.   Cheruvu M.   Mai N.   O’Keefe M.   Johnson-Rabidoux S.   Peterson C.   Kaufman E.   Vickery R.  

Publisher： Springer Publishing Company

ISSN： 0028-1298

Source： Naunyn-Schmiedeberg's Archives of Pharmacology, Vol.375, Iss.3, 2007-05, pp. : 205-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Peripherally Restricted Opioid Agonists as Novel Analgesic Agents

By  

Current Pharmaceutical Design, Vol. 10, Iss. 7, 2004-03 ,pp. : 743-757

Bentham Science Publishers

Access to resources Recommend Favorite

The peripheral opioid receptor antagonist methylnaltrexone alleviates opioid-induced constipation

By  

Reactions Weekly, Vol. 1, Iss. 1044-1045, 2005-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Ultraselective antagonists of the d-opioid receptor

By Lazarus L.H.   Salvadori S.   Temussi P.A.   Balboni G.   Guerrini R.   Bryant S.D.   Cooper P.S.  

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 45-47

Informa Healthcare

Access to resources Recommend Favorite

Methylnaltrexone for opioid-induced constipation

By  

Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Methylnaltrexone for opioid-induced constipation

By  

Reactions Weekly, Vol. 1, Iss. 1205, 2008-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite